Evidence map›Paper›PMID 36301550›Full record

ReviewCannabis and cannabinoid research2023

Cannabis in Adolescence: Lasting Cognitive Alterations and Underlying Mechanisms.

Andrew F Scheyer, Steven R Laviolette, Anne-Laure Pelissier, Olivier J J Manzoni

Open access · greenAbstract readReview
In one paragraph

Review in Cannabis and cannabinoid research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. The Developmental Trajectory to Cannabis Use Disorder.The American journal of psychiatry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Andrew F ScheyerINMED, INSERM U1249, Marseille, France.
Steven R LavioletteAddiction Research Group, University of Western Ontario, London, Ontario, Canada.
Anne-Laure PelissierINMED, INSERM U1249, Marseille, France.
Olivier J J ManzoniINMED, INSERM U1249, Marseille, France.ORCID 0000-0002-5579-6208
Inserm · FRWestern University · CA

Funding

Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalitiesR01DA046196 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH, MANZONI, OLIVIER JJ · 2018 to 2022
$1.6M
Sex-specific critical periods determine the effects of cannabinoids on the mesocorticolimbic systemR01DA043982 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH, MANZONI, OLIVIER JJ · 2017 to 2021
$1.5M
CIHR MOP-123378NIDA NIH HHS R01 DA043982NIDA NIH HHS R01 DA046196
6 · The paper itself

Abstract

Cannabis consumption during adolescence is an area of particular concern, owing to changes in the social and political perception of the drug, and presents a scientific, medical, and economic challenge. Major social and economic interests continue to push toward cannabis legalization as well as pharmaceutical development. As a result, shifting perceptions of both legal and illicit cannabis use across the population have changed the collective evaluation of the potential dangers of the product. The wave of cannabis legalization therefore comes with new responsibility to educate the public on potential risks and known dangers associated with both recreational and medical cannabis. Among these is the risk of long-term cognitive and psychological consequences, particularly following early-life initiation of use, compounded by high-potency and/or synthetic cannabis, and heavy/frequent use of the drug. Underlying these cognitive and psychiatric consequences are lasting aberrations in the development of synaptic function, often secondary to epigenetic changes. Additional factors such as genetic risk and environmental influences or nondrug toxic insults during development are also profound contributors to these long-term functional alterations following adolescent cannabis use. Preclinical studies indicate that exposure to cannabinoids during specific windows of vulnerability (e.g., adolescence) impacts neurodevelopmental processes and behavior by durably changing dendritic structure and synaptic functions, including those normally mediated by endogenous cannabinoids and neuronal circuits.

Indexed as

CannabinoidsCannabisHallucinogensAdolescentCannabinoid Receptor AgonistsCognitionHumansCannabinoid Receptor AgonistsCannabinoidsHallucinogensadolescencecannabiscognition

Identifiers

PMID36301550
PMCPMC9940816
OpenAlexW4307406658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.